Using genetic tests to predict antibiotic resistance in lung infections
Part of Infections clinical trials.
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a lower respiratory tract infection with at least two of these: fever or low body temperature, abnormal white blood cell count, or thick mucus
- You have already had a special genetic test (tNGS) on a sample from your lungs during this hospital stay
- The tNGS test showed high levels of Staphylococcus aureus, Acinetobacter baumannii, Klebsiella pneumoniae, or Pseudomonas aeruginosa
- A culture of fluid from your lungs (bronchoalveolar lavage) did not grow any of these bacteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This study tests a method called tNGS that looks for germs in your lung fluid. It aims to find why your pneumonia is not getting better, so doctors can choose the right treatment.
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
Hear when a new Antimicrobial Drug Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.